Drawing for KYOWA KIRIN

USPTO serial 79261181

KYOWA KIRIN

Reviewed by CopyMark Law Group

Reg. 6055565Status 707Renewal
Filing date
Status date
Registration date
May 19, 2020
Examiner
CHANG, ELIZABETH YI HSUAN
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with KYOWA KIRIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles T. J. Weigell

Charles T. J. Weigell Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd Street, 17th FloorNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cancer or malignant tumors, pain, hematological disorders, renal disease, endocrine diseases, immunity disorders, neurological, psychiatric and other central nervous system disorders [ ; pharmaceutical preparations for supportive care in the treatment of cancer or malignant tumors; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; cells for medical purposes; bacteriological culture mediums for medical and veterinary purposes; cell culture mediums for medical and veterinary purposes; reagent paper for medical purposes; gauze for dressings; empty capsules for pharmaceuticals; antiseptic absorbent cotton; adhesive plasters for medical purposes; bandages for dressings; lacteal flour for babies; dietary supplements; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies adapted for medical purposes; food for babies; dietary supplements for animals ]ACTIVE—
040[ Custom manufacture of pharmaceuticals; extraction, production and synthesis of pharmaceuticals for others; custom manufacture of industrial chemicals; custom manufacture of medical apparatus and medical instruments; manufacture of antibody-producing cells for others ]SECTION 71 - CANCELLED—
042Pharmaceutical research; research of chemicals; analysis of chemicals; testing, inspection or research of pharmaceuticals; testing, inspection or research of chemicals; [ testing, inspection or research of cosmetics; testing, inspection or research of foodstuff; ] providing technical advice relating to chemical research; providing technical advice relating to pharmaceutical development; providing technical advice relating to chemical development [ ; rental of laboratory apparatus; rental of laboratory instruments ]ACTIVE—
044Providing medical information [ ; medical examinations; preparation and dispensing of medication; dietary and nutritional guidance; veterinary services; rental of medical apparatus; rental of medical instruments ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 31, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Aug 31, 202671.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Aug 23, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 18, 2026ES71TEAS SECTION 71 RECEIVED—
May 23, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 19, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 29, 2021LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Oct 28, 2021COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Oct 28, 2021PLGLASSIGNED TO PARALEGAL—
Oct 23, 2021LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Dec 19, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 23, 2020XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 23, 2020XXCRGENERIC MADRID TRANSACTION CREATED—
Aug 19, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 19, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 3, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 3, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 28, 2020GPNXNOTIFICATION PROCESSED BY IB—
Feb 12, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 12, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 12, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 30, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 29, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 29, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 29, 2020ALIEASSIGNED TO LIE—
Jan 22, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 1, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 10, 2019CHLDCHANGE OF OWNER RECEIVED FROM IB—
Aug 9, 2019RFNTREFUSAL PROCESSED BY IB—
Jul 23, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 23, 2019RFRRREFUSAL PROCESSED BY MPU—
Jul 2, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 2, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 1, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 26, 2019DOCKASSIGNED TO EXAMINER—
Jun 26, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 20, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance